Slow release formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4880830
SERIAL NO

07012026

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A slow release formulation to be administered to humans or animals, comprising primary granules which contain an active ingredient and are in a secondary matrix of a water soluble/dispersible slow release material, the granules themselves comprising particles containing the active ingredients and in a primary matrix of a water soluble/dispersible slow release material. Optionally the formulation comprises a binder phase of a water insoluble slow release material having embedded therein secondary granules comprising the secondary matrix containing the primary matrix granules. The water soluble/dispersible material may be a polysaccharide and acacia and low viscosity methylcellulose are exemplified, as well as alginate and gelatine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ETHICAL PHARMACEUTICALS LIMITEDCAMBRIDGESHIRE BUSINESS PARK ELY CAMBRIDGESHIRE CB7 4EE UNITED KINGDOM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Rhodes, Alan Ely, GB 14 235

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation